secwatch.observer — SEC 8-K summary
======================================

Issuer:     CONMED Corp (CNMD)
CIK:        0000816956
Form:       8-K
Filed at:   2025-11-05T23:59:59+00:00
Accession:  0000816956-25-000054
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CONMED Q3 revenue up 6.7% to $338M; adjusted EPS $1.08; suspends dividend, authorizes $150M buyback
--------------------------------------------------------------------------------

- Diluted GAAP EPS $0.09 vs $1.57 YoY due to $19.7M product rationalization and $9.2M consulting costs.
- Adjusted diluted EPS $1.08 vs $1.05 YoY; full-year adjusted EPS guidance raised to $4.48-$4.53.
- Full-year revenue guidance narrowed to $1.365B-$1.372B; tariffs expected to reduce Q4 EPS by ~$0.07.
- Board authorized $150M share repurchase program; quarterly cash dividend suspended; at least $25M annual buybacks from 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/816956/000081695625000054/0000816956-25-000054-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/816956/000081695625000054/cnmd-20251105.htm
  HTML page:      https://secwatch.observer/filing/0000816956-25-000054

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer